Julie J Miller

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Radiation Induced

Newly Diagnosed

Epstein Barr Virus

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eric P Grewal, Leland G K Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage, Julie J Miller, Bob S Carter, Daniel P Cahill, William T Curry, Bryan D Choi
Mutant IDH modulates suppressive myeloid populations in malignant glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, Emil Ekanayake, Sirena K Khanna, Austin S Gamblin, Hui Zheng, Johan Skog, Julie J Miller, Anat O Stemmer-Rachamimov, Daniel P Cahill, Leonora Balaj, Bob S Carter
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas. Nature communications 15 (1) (2024)
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, Emil Ekanayake, Sirena K Khanna, Austin S Gamblin, Hui Zheng, Johan Skog, Julie J Miller, Anat O Stemmer-Rachamimov, Daniel P Cahill, Leonora Balaj, Bob S Carter
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas. Nature communications 15 (1) (2024)
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, Emil Ekanayake, Sirena K Khanna, Austin S Gamblin, Hui Zheng, Johan Skog, Julie J Miller, Anat O Stemmer-Rachamimov, Daniel P Cahill, Leonora Balaj, Bob S Carter
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas. Nature communications 15 (1) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, Emil Ekanayake, Sirena K Khanna, Austin S Gamblin, Hui Zheng, Johan Skog, Julie J Miller, Anat O Stemmer-Rachamimov, Daniel P Cahill, Leonora Balaj, Bob S Carter
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas. Nature communications 15 (1) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa, Logan Muzyka, Hiroaki Wakimoto, Daniel P Cahill, Julie J Miller
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Julie J Miller, Isabel C Arrillaga-Romany
IDH-mutant glioma: A new IDH1 inhibitor moves forward. Neuro-oncology 25 (2) (2023)
Julie J Miller
Targeting IDH-Mutant Glioma. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 19 (6) (2022)
Julie J Miller, Nancy Wang
Body imaging for newly diagnosed CNS lymphoma: Evaluating the utility of the evaluation. Neuro-oncology 24 (3) (2022)
Julie J Miller, Isabel C Arrillaga-Romany
IDH-mutant glioma: A new IDH1 inhibitor moves forward. Neuro-oncology (2022)
Julie J Miller
Targeting protein arginine methylation to death. Neuro-oncology 23 (9) (2021)
Kensuke Tateishi, Yohei Miyake, Masahito Kawazu, Nobuyoshi Sasaki, Taishi Nakamura, Jo Sasame, Yukie Yoshii, Toshihide Ueno, Jun Watanabe, Yuko Matsushita, Norio Shiba, Naoko Udaka, Kentaro Ohki, Alexandria L Fink, Shilpa S Tummala, Manabu Natsumeda, Naoki Ikegaya, Mayuko Nishi, Makoto Ohtake, Ryohei Miyazaki, Jun Suenaga, Hidetoshi Murata, Ichio Aoki, Julie J Miller, Yukihiko Fujii, Akihide Ryo, Shoji Yamanaka, Hiroyuki Mano, Daniel P Cahill, Hiroaki Wakimoto, Andrew S Chi, Tracy T Batchelor, Motoo Nagane, Koichi Ichimura, Tetsuya Yamamoto
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma. Cancer research 80 (23) (2020)
Hiroaki Nagashima, Christine K Lee, Kensuke Tateishi, Fumi Higuchi, Megha Subramanian, Seamus Rafferty, Lisa Melamed, Julie J Miller, Hiroaki Wakimoto, Daniel P Cahill
Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells. Cancer discovery 10 (11) (2020)
Gilbert Youssef, Julie J Miller
Lower Grade Gliomas. Current neurology and neuroscience reports 20 (7) (2020)
Kensuke Tateishi, Taishi Nakamura, Tareq A Juratli, Erik A Williams, Yuko Matsushita, Shigeta Miyake, Mayuko Nishi, Julie J Miller, Shilpa S Tummala, Alexandria L Fink, Nina Lelic, Mara V A Koerner, Yohei Miyake, Jo Sasame, Kenji Fujimoto, Takahiro Tanaka, Ryogo Minamimoto, Shigeo Matsunaga, Shigeo Mukaihara, Takashi Shuto, Hiroki Taguchi, Naoko Udaka, Hidetoshi Murata, Akihide Ryo, Shoji Yamanaka, William T Curry, Dora Dias-Santagata, Tetsuya Yamamoto, Koichi Ichimura, Tracy T Batchelor, Andrew S Chi, A John Iafrate, Hiroaki Wakimoto, Daniel P Cahill
PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)
Julie J Miller, Helen A Shih, Ovidiu C Andronesi, Daniel P Cahill
Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications. Cancer 123 (23) (2017)